|
IPC set to digitize Indian Pharmacopoeia
|
|
Laxmi Yadav, Mumbai
November 30 , 2022
|
|
|
The Indian Pharmacopoeia Commission (IPC) is set to digitize Indian Pharmacopoeia (IP) to increase its coverage and facilitate its simple use.
The ninth edition of IP launched by Union minister of health and family welfare Dr Mansukh Mandaviya on July 1 this year has four volumes which are quite heavy. Digitization will help stakeholders access IP from anywhere thus saving their cost and time.
IPC on November 23, 2022 invited tender on government e marketplace (GeM portal) from eligible and qualified IT firms related to online portal development, application development, data digitization or online content management etc. for project—‘Digitization of Indian Pharmacopoeia. The bid is open from November 22, 2022. The last date for submission of bid is December 13, 2022.
IP 2022 is quite bulky. It contains 92 new monographs for drugs, 12 new general chapters, 1,245 monographs for formulations, 930 monographs for active pharmaceutical ingredients (APIs) as well as dissolution specifications for all prolonged release formulations.
Till date there are no such specifications for prolonged release formulations. It will impact public health in the long term in a big way.
Of the 92 new monographs, there are 60 chemical, 21 vitamins, minerals, amino acids, fatty acids etc., 3 biotechnology-derived therapeutic products, 4 human vaccines, 2 blood and blood related products, 2 herbs and herbal related products, and 7 phytopharmaceutical ingredient category monographs.
Besides this, IP 2022 also contains 652 pharma reference substances covering 70 per cent requirement of reference materials used for quality control in the country. Currently, there are 300 impurity standards in IP which are crucial for managing pharmaceutical quality. It also includes remdesivir API and injection monographs, favipiravir API and tablets monographs, 2DG API & powder & sachet monographs, Rapid microbiological testing—draft chapter. This has led to the total number of 3,152 monographs in the current edition of IP.
Several monographs and general chapters have also been revised to update them as per current global requirements and to harmonize with other pharmacopoeias like USP, BP, EP, etc. The harmonization of standards with global standards is expected to help IP getting recognized and accepted in foreign countries.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|